To Tirzepatida it became one of the drugs most talked-about in recent years. The interest has grown, mainly because of its track record in the treatment of type 2 diabetes and in the control of chronic weight.
You've probably heard of it through the Mounjarosaw reports of people on social media and found comparisons with medications such as Ozempic, and Wegovy.
But in the end, what is the Tirzepatida, how does it work in the body, and that it drew so much attention.
The Tirzepatida it has a mechanism that is different from many of the drugs that were known earlier: it acts simultaneously on the receptors of the GIP and GLP-1, which is involved in various processes related to the body's metabolism, glucose control, appetite, and food intake.
In this article, you are going to know in a simple way that scientists have known about the Tirzepatida, their indications, their effects on the body and is the major health care related to the treatment.
- Important: this content has informational purposes only and should not replace the consultation, diagnosis, and follow-up carried out by a health care professional. Do not start, stop, or change the treatment Tirzepatida on their own.
What is the Tirzepatida?
To Tirzepatida it is a medicine for long duration of action, which acts as an agonist of the receptor GIP and GLP-1.
It is the main active ingredient of this medicine Mounjarodeveloped by Eli Lilly.
In Brazil, the Mounjaro it was first recorded by the brazilian health surveillance agency, in 2023, as the drug is associated with the diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
In the year 2025, the Fda approved a new indication, the chronicle of the weight, including the loss and maintenance of weight, and in some adults with obesity or overweight is associated with the at least one condition related to your weight.
In April 2026, the type-2 diabetes has also been extended to pediatric patients 10 years and older.
Tirzepatida and Mounjaro are they the same thing?
It is common to use the two names, as if they were exactly the same, but there is a difference.
Tirzepatida is the name of the active ingredient.
Mounjaro is the brand name for a medicine that contains the Tirzepatida.
It's like the difference between a drug and a brand that uses this substance is in the details.
For this reason, the scientific studies you can talk about in Tirzepatidawhile the information leaflet and business records, may specifically refer to the Mounjaro.
How does it work Tirzepatida?
One of the main features of the Tirzepatida it is simultaneously serve on the receptors for hormones:
- GIP — polypeptide insulinotrópico-dependent glucose;
- GLP-1 — peptide that is similar to glucagon in type 1.
These receptors are involved in different metabolic processes.
According to the Fda, the effects of the Tirzepatida is an improvement of insulin sensitivity, increased insulin secretion in a manner dependent on the glucose and the reduction of glucagon, a delay in gastric emptying and reduction of food intake.
It is precisely this combination of mechanisms, which help to better understand its effect on both type 2 diabetes and body weight.
What are the GLP-1 and GIP?
GLP-1 and GIP, are the hormones produced naturally by the body and are part of a group known as the incretinas.
They are released in response to food, and participate in the control of metabolism.
The GLP-1 that is related to, among other things, the control of blood glucose, and the insulin secretion, the gastric emptying time, and in the regulation of appetite.
The GIP will also participate in the response of glucose and insulin secretion.
The Tirzepatida has been developed in order to activate the receptors for these hormones.
This is one of the main differences between it and the drugs on the basis of the semaglutida that act on the receptor for GLP-1, but not in the receptor for GIP.
How to Tirzepatida the influence of the class.
One of the most attractive of those who use Tirzepatida this is a change in appetite.
The action of the receptors for GIP and GLP-1 can increase the feeling of fullness and reducing the amount of food a person eats.
Some people may experience:
- less hungry throughout the day
- again faster.
- difficult to finish a meal large
- the lower the interest for a certain food.
- over longer periods of time between meals.
This does not mean, however, that the goal of treatment is to completely suppress the pangs of hunger.
Your body still needing to get the protein, vitamins, and minerals, fluids, and energy.
A reduction in excess in the diet can also lead to problems and should be discussed with the professionals in charge of the follow-up.
The Tirzepatida let's be digested more slowly?
Yes Tirzepatida it slows down the gastric emptying time.
In the simplest of terms, this means that the contents of the stomach, it may take longer than usual to be followed by the digestive system.
The Fda notes that this effect tends to diminish with the passage of time.
The slower gastric emptying help you to understand the sense of satiety, but it is also closely related to some of the gastrointestinal side effects that may occur during the treatment period.
Some of these include nausea, vomiting, diarrhea, constipation, indigestion, and abdominal discomfort.
The purpose of the Tirzepatida?
In Brazil, there are indications approved in the Mounjaro primarily involve diabetes mellitus, type 2 and the control of chronic weight.
Type 2 Diabetes
The Tirzepatida was first recorded in Brazil in order to assist in the control of blood glucose levels in adults with type 2 diabetes mellitus, in conjunction with a sensible diet and exercise.
In April 2026, the Fda has extended this to include pediatric patients 10 years and older.
The control of chronic weight
In June of that by 2025, the Mounjaro also have an approved indication in Brazil for the control of chronic and weight of adults:
- with a BMI equal to or greater than 30 kg/m2; or
- with a BMI equal to or greater than 27 kg/m2) and at least one condition related to your weight.
The Fda cites as examples of high blood pressure, dyslipidemia, obstructive sleep apnea, cardiovascular disease, pre-diabetes, and type 2 diabetes.
The treatment is recommended in conjunction with a diet with reduced calories and increased physical activity.
Tirzepatida it really makes you lose weight?
Clinical trials have demonstrated significant reductions in weight and in certain populations, using the Tirzepatida.
One of the studies, the most well-known is the SURMOUNT-1published in the New England Journal of Medicine.
The study followed 2.539 in adults with obesity or overweight and that at least one complication related to the weight of it, without diabetes, for 72 weeks.
The average change in body weight was approximately as follows:
- -15,0% with Tirzepatida is 5 mg;
- -19,5% with Tirzepatida 10%;
- -20,9% with Tirzepatida 15 mg;
- -3,1% with placebo.
These results have a huge impact.
But there is a very important information:
this does not mean that those who use the Tirzepatida you will lose not necessarily to 15%, or 20% or any other percentage that is specific to the weight.
The numbers are a medium-sized seen the inside of a clinical trial.
The answer may be different.
Why everybody is talking about the Tirzepatida?
The popularity of the Tirzepatida didn't come out of a single factor.
The results of these studies have called attention to
Significant results are related to the weight of the body, made with the Tirzepatida to receive the great attention of the scientific community, the media, and social media.
It has a mechanism of action different to
The performance given the receptors for GIP and GLP-1 to describe the Tirzepatida of a variety of medications known before.
Social networks have increased in their popularity
Reports on Mounjaro, Ozempic, Wegovy, and other so-called “pen emagrecedoras”, have gained millions of views.
This has made the drugs that were known primarily by the offices on popular issues.
For the treatment of obesity have changed
Obesity is considered a disease with a chronic and multifactorial.
The development of new drugs has broadened the possibilities of therapy, and it has also increased the interest of the people by the drug treatment.
At the same time, this popularity has brought us to a problem: a lot of incorrect information started to circulate.
Tirzepatida is the same as the Ozempic?
No.
Mounjaro and Ozempic they are different drugs.
The Mounjaro contains Tirzepatidawhile the Ozempic contains semaglutida.
The main difference is in the mechanism of action is to:
Tirzepatida: GIP + GLP-1
Semaglutida: GLP-1
In addition to this, they have servings, directions, and the schemes of their own.
There is no simple conversion of the dose between the two drugs.
Read more: What is the difference between Mounjaro and Ozempic?
What are the side effects of the Tirzepatida?
As with other drugs, the Tirzepatida may cause side effects,.
Among the reactions of the more well known are mainly gastro-intestinal symptoms.
You may experience:
- nausea
- diarrhea;
- the reduction of appetite;
- vomiting;
- constipation;
- diet;
- abdominal pain or discomfort.
In this study SURMOUNT-1, the most frequent adverse events were gastrointestinal disorders, which are generally mild to moderate, and occurred mainly during the period of the increase of the dose.
This does not mean that all people will experience these symptoms.
Read more: Tirzepatida: what are some of the most common side effects?
Tirzepatida gives you motion sickness?
It can be done.
The nausea is among the gastrointestinal side effects associated with treatment with Tirzepatida.
A few people have reported a few symptoms, while others may display an absence of more substantial.
It is important to observe, particularly, the intensity, the duration, and the presence of additional symptoms.
Nausea and intense, repeated vomiting, or difficulty in maintaining the moisture they deserve to professional judgment.
Read more: Nausea, with Tirzepatida: is it normal?
It is true that Tirzepatida it is a similar weight loss”?
The phrase went on to become extremely popular, but it makes it much easier than the medicine, it really is.
To Tirzepatida is not just a substance, intended to make anyone lose a few pounds.
It operates in the systems, hormonal, and metabolic features clinical indications that are defined.
For this reason, the use of it should not be decided solely on the basis of:
“a friend used to”
“I saw someone on TikTok”
or
“I want to lose five pounds quickly.
The evaluation of the benefits and the risks that it needs to be individualized.
Tirzepatida need a recipe?
Yes.
From June 23, 2025, pharmacies and drug stores, brazilian, need to retain the revenue from the drug agonists of the GLP-1 are included in the regulation, such as Mounjaro, Ozempic, and Wegovy.
A prescription must be done in two ways, and have a validity of 90 days.
The Fda has adopted a change in the face of concern about the inappropriate use of these drugs and the adverse events related in particular to the use of off-the particulars have been approved.
Can I buy Tirzepatida on the internet?
It is necessary to be very careful with the offers you found on the internet and on social networks.
Products without any registration, fakes, or they are produced in an irregular manner, it can pose significant risks.
In march, 2026, for example, the Fda ordered the seizure and prohibit the marketing, distribution, export, import, manipulation, and propaganda, a tirzepatida produced illegally by a particular company.
For this reason, the strength of the product is just as important as the statute of limitations.
Medicines that should be purchased-channel regulated.
Tirzepatida is it secure?
A medicine is approved, it passes through the evaluation of quality, safety, and effectiveness of their information.
This it does not mean that it is risk-free.
The Tirzepatida has contraindications, warnings, and potential adverse effects.
For example, officials from the FDA, which include warnings that are related to the reactions of the gastro-intestinal severe pancreatitis, gallbladder disease, low blood glucose, in certain combinations, and other situations that need to be taken into account.
For this reason, security should not be confused with a “no-track”.
The Tirzepatida replace diet and exercise?
No.
For the control of chronic weight, the recommendation is approved by the Fda calls for the use of the medicinal product in conjunction with a diet reduced in calories, and increase physical activity.
This is especially important because losing weight is not the only goal is to be relevant.
During the process, it is also important to consider the following:
- the quality of the food;
- adequate intake of dietary protein
- micro;
- hydration;
- physical activity;
- the maintenance of muscle mass;
- health is metabolic.
The product is a tool in the treatment of space.
It is possible to use the Tirzepatida without experiencing any side effects?
Yes.
The experience varies greatly between people.
A person may present a health care professional to another can be changes in the bowel, and the other one can virtually do not realize the adverse effects are relevant to you.
Don't feel the effects too it does not mean that the medication is not working.
The severity of adverse effects, it should not be used as a measure of the effectiveness of the treatment.
Tirzepatida works all over the world?
There is no drug that is present in exactly the same response in all people.
The results of the study showed a medium to large groups.
In practice, the answer may vary according to individual circumstances.
Because of this, compare your result with that of the other person in the social networks, it is generally not a good measure of the treatment.
Frequently asked questions about Tirzepatida
What is the Tirzepatida?
Tirzepatida is a prescription medication that acts as an agonist of the receptors for GIP and GLP-1. This is the active ingredient in the Mounjaro.
How does it work Tirzepatida?
It also influences processes that are related to the secretion of insulin, glucagon, insulin sensitivity, gastric emptying, satiety, appetite, and food intake.
The purpose of the Tirzepatida?
In Brazil, the Mounjaro has signs related to type 2 diabetes mellitus and chronic weight in the general population who meet the criteria for approval.
Tirzepatida lose weight?
Clinical trials have demonstrated significant reductions in weight and in certain populations. The net result to the individual, however, can vary.
Tirzepatida is Mounjaro?
Tirzepatida is the main active ingredient. Mounjaro is the brand name for a medicine that contains the Tirzepatida.
Tirzepatida is the same as the Ozempic?
No. Ozempic contains semaglutida, as Mounjaro contains Tirzepatida. The drugs also have different mechanisms of action.
Tirzepatida need a recipe?
Yes. In Brazil, the Mounjaro is sold " as is on the order of a retention-of-prescription at the pharmacy.
Tirzepatida cause any side effects?
It may cause you. The most common effects are mainly related to the gastrointestinal system, such as nausea, diarrhea, vomiting, and constipation.
All over the world, you lose a lot of weight with a Tirzepatida?
No. The results presented in the study are averages and do not represent a promise by an individual to lose weight.
Conclusion
To Tirzepatida it became one of the drugs most talked-about in recent years because it has a mechanism of action that is different, and the results of important studies related to type 2 diabetes, and weight control.
His acting simultaneously on the receptors of the GIP and GLP-1 the influence of processes that are related to the glucose, insulin, satiety, appetite, and food intake.
The study will help in understanding why the interest in the Tirzepatida grew up so fast.
But, there is a vast difference between the understanding of the results of research and turn it into a medicine, a trend the internet.
The Tirzepatida has specific indications, adverse effects, contraindications, and the need for professional support.
For this reason, the information found in the social networks, they should be analyzed with caution.
Personal accounts can help you understand the different experiences, but they are no substitute for evidence and scientific information for the regulatory evaluation or individual.
The most popular Tirzepatida becomes, the more important it is to separate the the science, experience, and advertising.
References
- The brazilian National agency of Sanitary Surveillance (Anvisa) — Mounjaro® (Tirzepatida): a new record.
- The brazilian National agency of Sanitary Surveillance (Anvisa) — Mounjaro® (Tirzepatida): a new indication for the control of chronic weight.
- The brazilian National agency of Sanitary Surveillance (Anvisa) — The expansion of the indication of the Mounjaro® type 2 diabetes in pediatric patients.
- The brazilian National agency of Sanitary Surveillance (Anvisa) — The retention of the revenue for the drug agonists of the GLP-1.
- The U. S. Food and Drug Administration (FDA) — Mounjaro® (tirzepatide): Prescribing Information.
- Jastreboff AM, et al. — Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine.
Content is up-to-date in August, 2026.
Read On To Find Out
Nausea, with tirzepatida: is it normal?
Tirzepatida: what it is, how it works, and why everyone is talking about it
Tirzepatida in 2026: top 5 Major Trends-and what You Need to Know in order to Not Lose Muscle
Mounjaro or Ozempic? Make sure you understand the difference
